← FDA Drug Approvals (Drugs@FDA)
AMPICILLIN AND SULBACTAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA SPECLTS · Approved 2010-09-20
Drug application
- FDA Application #
ANDA090340- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMPICILLIN AND SULBACTAM
- Generic name
- AMPICILLIN SODIUM AND SULBACTAM SODIUM
- Active ingredients
- AMPICILLIN SODIUM; SULBACTAM SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- EUGIA PHARMA SPECLTS
- Manufacturer
- Eugia US LLC
- First approval
- 2010-09-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown